By Nick Johnson (Apyx) In 2025 Shareholder News, RenuvionPosted May 13, 2025APYX MEDICAL CORPORATION RECEIVES FDA CLEARANCE FOR THE AYON BODY CONTOURING SYSTEM™ READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, J-Plasma, RenuvionPosted May 8, 2025APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, RenuvionPosted May 1, 2025Renuvion Introduces Television Star Dolores Catania as Chief of Confidence READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, RenuvionPosted April 29, 2025APYX MEDICAL CORPORATION ANNOUNCES TWO PEER-REVIEWED PUBLICATIONS ON THE USE OF RENUVION IN ABDOMINAL BODY CONTOURING PROCEDURES READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, J-Plasma, RenuvionPosted April 24, 2025APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2025 FINANCIAL RESULTS ON MAY 8, 2025 READ MORE
By Nick Johnson (Apyx) In 2020 Shareholder News, 2025 Shareholder News, RenuvionPosted March 25, 2025RENUVION WINS 2025 NEWBEAUTY AWARD FOR “BEST MINIMALLY INVASIVE SKIN TIGHTENER” READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, 2025 Shareholder News, J-Plasma, RenuvionPosted March 13, 2025APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, 2025 Shareholder News, J-Plasma, RenuvionPosted February 28, 2025APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2024 FINANCIAL RESULTS ON MARCH 13, 2025 READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, 2025 Shareholder News, J-Plasma, RenuvionPosted January 13, 2025APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2024 REVENUE RESULTS READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, RenuvionPosted January 6, 2025APYX MEDICAL CORPORATION SUBMITS 510(K) PREMARKET NOTIFICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION FOR THE AYON BODY CONTOURING SYSTEM™ READ MORE
